Latest News about NASDAQ:CRDL
Recent news which mentions NASDAQ:CRDL
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q2 2024
August 12, 2024
Tickers
CRDL
From InvestorPlace
Tags
NASDAQ:CRDL
From News Direct
From News Direct
From News Direct
Tags
NASDAQ:CRDL
From News Direct
Tickers
CRDL
From InvestorPlace
Tickers
CRDL
From InvestorPlace
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
Tickers
CRDL
Tags
NASDAQ:CRDL
From News Direct
Cardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol
October 11, 2023
From News Direct
Cardiol Therapeutics says first patient enrolled in Phase 2 study of CardiolRx for Pericarditis
January 17, 2023
From News Direct
Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
December 16, 2022
From News Direct
Tickers
CRDL
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.